Congress and the Bush administration have rationed Pseudoephedrine under the guise of the war on drugs. The replacement product--Phenylephrine--might as well be a placebo. This article assembles evidence that the switch was designed to subsidize a well-heeled Germany company that spent millions in lobbying for the law.